Zoledronic Acid API Powder

Name: Zoledronic Acid API Powder
Brand: NEXALLE LLP
Price: 400000 INR
Availability: InStock

Price 400000 INR/ Kilograms

Get a Price/Quote

MOQ : 10 Kilograms

Zoledronic Acid API Powder Specification

Material
Zoledronic Acid

Purity
Min. 99%

Molecular Formula
C5H10N2O7P2

Function
Anti Infective

Place of Origin
India

Appearance
White to off-white Powder

Color
White

Storage Instructions
Store in cool, dry place

Grade
IP BP EP USP IH

Product Type
API Powder

Composition
Zoledronic Acid

Dosage Form
Bulk API

CAS No
165800-06-6

Form
Powder

Grade Standard
IP

Molecular Weight
272.09 g/mol

Shelf Life
24 months

Type of API
Anti Infective

Solubility
Soluble in water

Packaging Size
100 gram/1 kg

Melting Point
239-241°C

Odor
Odorless

Packaging Type
Drum

Zoledronic Acid API Powder Trade Information

Minimum Order Quantity
10 Kilograms

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Kilograms Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About Zoledronic Acid API Powder

Explore the inestimable potential of Zoledronic Acid API Powder, meticulously manufactured in India for uncompromising quality. With a superb molecular weight of 272.09 g/mol and a high purity minimum of 99%, this anti-infective API is unassailable in efficacy and reliability. Find instant checkout options for bulk orders, with packaging available in 100 grams or 1 kg drums. Odorless and water-soluble, its white to off-white powder form ensures seamless formulation. With a shelf life of 24 months and internationally recognized grade standards-IP, BP, EP, USP, IH-Zoledronic Acid API Powder is your trusted choice for commercial pharmaceutical manufacturing.

Specific Usage & Application of Zoledronic Acid API Powder

Zoledronic Acid API Powder is specifically utilized in the formulation of anti-infective pharmaceuticals for intravenous administration. The application method requires careful compounding into injectable solutions, tailored for use in clinical and hospital settings. This API offers targeted application against infections, ensuring maximal therapeutic benefit. Bulk dosage form allows high-volume manufacturing, accommodating the stringent demands of large-scale healthcare providers. Apply via standard pharmaceutical procedures for optimum efficacy and patient safety.

Main Export Markets, Packaging & FOB Details

Zoledronic Acid API Powder enjoys a superb reputation in international export markets including Europe, Southeast Asia, and the Middle East. List price and expenditure depend on the requested packaging size-100g or 1kg drums-each ensuring pristine condition until use. The rate and terms are favorable for bulk procurement, with prompt shipping via major Indian FOB ports to guarantee swift delivery. This robust packaging keeps the powder's integrity intact throughout transportation and storage.

FAQ's of Zoledronic Acid API Powder:

Q: How should Zoledronic Acid API Powder be stored before use?

A: Store Zoledronic Acid API Powder in a cool, dry place, away from direct sunlight and humidity, to preserve its efficacy and maintain the stipulated 24-month shelf life.

Q: What is the recommended application method for this bulk API?

A: The powder should be compounded into sterile injectable solutions under pharmaceutical manufacturing guidelines, making it suitable for clinical and hospital applications.

Q: When is Zoledronic Acid API Powder most beneficial in pharmaceutical production?

A: It is particularly advantageous when formulating high-purity anti-infective drugs that demand stringent quality standards and reliable performance.

Q: Where does the manufacturing of Zoledronic Acid API Powder take place?

A: This API is expertly produced in India, adhering to international grade standards and quality protocols.

Q: What are the key benefits of using Zoledronic Acid API Powder for manufacturing?

A: Benefits include its high purity (min. 99%), broad international grading compliance (IP, BP, EP, USP, IH), odorless nature, water solubility, and a robust shelf life, ensuring consistent outcomes in final formulations.